Medication Adherence Pattern for Benign Prostatic Hyperplasia: A Cross-Sectional Study

Authors

  • Jyoti Tara Manandhar Shrestha Kathmandu University School of Medical Sciences, Dhulikhel, Nepal https://orcid.org/0000-0001-7403-3874
  • Hem Nath Joshi Kathmandu University School of Medical Sciences, Dhulikhel, Nepal
  • Prabin Neupane Kathmandu University School of Medical Sciences, Dhulikhel, Nepal

Keywords:

Adherence, Benign prostate hyperplasia, Lower urinary tract symptom, Non-adherence

Abstract

Introduction: Benign prostate hyperplasia is one of the most common diseases and a common cause of lower urinary tract symptoms in aging men. Various disease management approaches to optimize the patient’s long life and efficient status where patient adherence to the prescribed treatment plays a vital role. This study evaluated the medication adherence pattern of the patients to obtain successful treatment outcomes.

Methods: A cross-sectional study was conducted in out-patient department of urology in a tertiary care hospital. Patients diagnosed with benign prostate hyperplasia were interviewed using a structured questionnaire.

Results: The high expenses of medicine, fear of medication, lack of symptomatic relief were factors that showed statistically significant (p < 0.05) difference between adherent and non-adherent group. Similarly, the duration of diagnosis of the adherent group was significantly less than the non-adherent group including the pattern of physical activities (p < 0.05). Adherent group also had more participants working in business and services occupation compared to the non-adherent group.

Conclusion: The general attitude (such as fear of medication and lack of symptomatic relief) is seen as major factors that affect adherent pattern in benign prostate hyperplasia patients. These issues can be solved using proper guidance. However, the cost of medicines also posts an immense issue for the non-adherent group.

Downloads

Download data is not yet available.
Abstract
56
PDF
103

Author Biographies

Jyoti Tara Manandhar Shrestha, Kathmandu University School of Medical Sciences, Dhulikhel, Nepal

Associate Professor, Department of Pharmacology

Hem Nath Joshi, Kathmandu University School of Medical Sciences, Dhulikhel, Nepal

Associate Professor, Department of Urology

Prabin Neupane, Kathmandu University School of Medical Sciences, Dhulikhel, Nepal

Research Assistant, Department of Pharmacology

Downloads

Published

2020-10-30

How to Cite

Shrestha, J. T. M., Joshi, H. N., & Neupane, P. (2020). Medication Adherence Pattern for Benign Prostatic Hyperplasia: A Cross-Sectional Study. Journal of Lumbini Medical College, 8(2), 225–232. Retrieved from https://www.nepjol.info/index.php/JLMC/article/view/40829

Issue

Vol. 8 No. 2 (2020)

Section

Original Research Articles

License

Copyright (c) 2020 Jyoti Tara Manandhar Shrestha, Hem Nath Joshi, Prabin Neupane

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The Journal of Lumbini Medical College (JLMC) publishes open access articles under the terms of the Creative Commons Attribution(CC BY) License which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

JLMC requires an exclusive licence allowing to publish the article in print and online.

The corresponding author should read and agree to the following statement before submission of the manuscript for publication,

License agreement
In submitting an article to Journal of Lumbini Medical College (JLMC) I certify that:

  1. I am authorized by my co-authors to enter into these arrangements.
  2. I warrant, on behalf of myself and my co-authors, that:
    • the article is original, has not been formally published in any other peer-reviewed journal, is not under consideration by any other journal and does not infringe any existing copyright or any other third party rights;
    • I am/we are the sole author(s) of the article and have full authority to enter into this agreement and in granting rights to JLMC are not in breach of any other obligation;
    • the article contains nothing that is unlawful, libellous, or which would, if published, constitute a breach of contract or of confidence or of commitment given to secrecy;
    • I/we have taken due care to ensure the integrity of the article. To my/our - and currently accepted scientific - knowledge all statements contained in it purporting to be facts are true and any formula or instruction contained in the article will not, if followed accurately, cause any injury, illness or damage to the user.
  3. I, and all co-authors, agree that the article, if editorially accepted for publication, shall be licensed under the Creative Commons Attribution License 4.0. If the law requires that the article be published in the public domain, I/we will notify JLMC at the time of submission, and in such cases the article shall be released under the Creative Commons 1.0 Public Domain Dedication waiver. For the avoidance of doubt it is stated that sections 1 and 2 of this license agreement shall apply and prevail regardless of whether the article is published under Creative Commons Attribution License 4.0 or the Creative Commons 1.0 Public Domain Dedication waiver.
  4. I, and all co-authors, agree that, if the article is editorially accepted for publication in JLMC, data included in the article shall be made available under the Creative Commons 1.0 Public Domain Dedication waiver, unless otherwise stated. For the avoidance of doubt it is stated that sections 1, 2, and 3 of this license agreement shall apply and prevail.

Please visit Creative Commons web page for details of the terms.